Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-HGFR/c-Met Antibody (4V580) (Alias: MET proto-oncogene, receptor tyrosine kinase)

Catalog No. TMAY-01071 Copy Product Info
🥰Excellent
Anti-HGFR/c-Met Antibody (4V580) is a Rabbit antibody targeting HGFR/c-Met. Anti-HGFR/c-Met Antibody (4V580) can be used in FCM.

Anti-HGFR/c-Met Antibody (4V580)

Copy Product Info
🥰Excellent
Catalog No. TMAY-01071
Alias MET proto-oncogene, receptor tyrosine kinase

Anti-HGFR/c-Met Antibody (4V580) is a Rabbit antibody targeting HGFR/c-Met. Anti-HGFR/c-Met Antibody (4V580) can be used in FCM.

Anti-HGFR/c-Met Antibody
(4V580)
Pack SizePriceUSA StockGlobal StockQuantity
20 μL$927-10 days7-10 days
100 μL$2697-10 days7-10 days
In stock · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Cart
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-HGFR/c-Met Antibody (4V580) is a Rabbit antibody targeting HGFR/c-Met. Anti-HGFR/c-Met Antibody (4V580) can be used in FCM.
SynonymsMET proto-oncogene, receptor tyrosine kinase
Ig Type
Rabbit IgG
Clone
4V580
Reactivity
Human
Specificity
Human c-MET/HGFR
Verified Activity
Flow cytometric analysis of Human C-Met(HGFR) expression on HepG2 cells. Cells were stained with purified anti-Human C-Met(HGFR), then a FITC-conjugated second step antibody. The histogram were derived from gated events with the forward and side light-scatter characteristics of intact cells.
Application
Recommended Dose
FCM: 1:25-1:100
Antibody Type
Monoclonal
Host SpeciesRabbit
ConstructionThis antibody was obtained from a rabbit immunized with purified, recombinant Human c-Met / HGFR (rh c-Met / HGFR; TMPY-01296; NP_000236.2; Met1-Thr932).
PurificationProtein A
AppearanceLiquid
Formulation0.2 μm filtered solution in PBS
Research BackgroundHepatocyte growth factor receptor (HGFR), also known as c-Met or mesenchymal-epithelial transition factor (MET), is a receptor tyrosine kinase (RTK) that is overexpressed and/or mutated in a variety of malignancies. HGFR protein is produced as a single-chain precursor, and HGF is the only known ligand. Normal HGF/HGFR signaling is essential for embryonic development, tissue repair, or wound healing, whereas aberrantly active HGFR has been strongly implicated in tumorigenesis, particularly in the development of invasive and metastatic phenotypes. HGFR protein is a multifaceted regulator of growth, motility, and invasion, and is normally expressed by cells of epithelial origin. Preclinical studies suggest that targeting aberrant HGFR signaling could be an attractive therapy in cancer.Cancer ImmunotherapyImmune CheckpointImmunotherapyTargeted Therapy
Related Conjugates and Formulations
Conjucates
Unconjugated
Others Formats
APC/FITC/PE
Antibody Types Available
4
Antigen Details
Immunogen
Recombinant Protein: Human c-Met / HGFR protein (TMPY-01296)
Antigen Species
Human
Biology Area
Cancer Drug Targets, Receptor Tyrosine Kinases (RTKs)
Chemical Properties
Stability & Storage
Stability & StorageStore at 2°C-8°C for 1 month. Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. Preservative-Free.
TransportShipping with blue ice.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Anti-HGFR/c-Met Antibody (4V580) | purchase Anti-HGFR/c-Met Antibody (4V580) | Anti-HGFR/c-Met Antibody (4V580) cost | order Anti-HGFR/c-Met Antibody (4V580)